This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Sep 15;27(11):1355-6.

doi: 10.1002/mds.25141.

An important step towards translation of stem cell therapies in clinical applications for neurodegenerative diseases and beyond?

Ralf Reilmann¹

Affiliations

Affiliation

¹ EHDN Huntington Center Münster & EHDN Neuroprotective Therapy Working Group, Department of Neurology, University Clinic Muenster, Westfaelische-Wilhelms University of Muenster, Muenster, Germany.

PMID: 23166927
DOI: 10.1002/mds.25141

Comment

An important step towards translation of stem cell therapies in clinical applications for neurodegenerative diseases and beyond?

Ralf Reilmann. Mov Disord. 2012.

. 2012 Sep 15;27(11):1355-6.

doi: 10.1002/mds.25141.

Author

Ralf Reilmann¹

Affiliation

¹ EHDN Huntington Center Münster & EHDN Neuroprotective Therapy Working Group, Department of Neurology, University Clinic Muenster, Westfaelische-Wilhelms University of Muenster, Muenster, Germany.

PMID: 23166927
DOI: 10.1002/mds.25141

No abstract available

PubMed Disclaimer

Comment on

Direct reprogramming of fibroblasts into neural stem cells by defined factors.
Han DW, Tapia N, Hermann A, Hemmer K, Höing S, Araúzo-Bravo MJ, Zaehres H, Wu G, Frank S, Moritz S, Greber B, Yang JH, Lee HT, Schwamborn JC, Storch A, Schöler HR. Han DW, et al. Cell Stem Cell. 2012 Apr 6;10(4):465-72. doi: 10.1016/j.stem.2012.02.021. Epub 2012 Mar 22. Cell Stem Cell. 2012. PMID: 22445517

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley